124 related articles for article (PubMed ID: 37205914)
1. Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
Saran U; Chandrasekaran B; Tyagi A; Shukla V; Singh A; Sharma AK; Damodaran C
Front Pharmacol; 2023; 14():1207589. PubMed ID: 37205914
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
Saran U; Chandrasekaran B; Tyagi A; Shukla V; Singh A; Sharma AK; Damodaran C
Front Pharmacol; 2024; 15():1420266. PubMed ID: 38860169
[TBL] [Abstract][Full Text] [Related]
3. A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
Saran U; Chandrasekaran B; Tyagi A; Shukla V; Singh A; Sharma AK; Damodaran C
Front Pharmacol; 2023; 14():1150774. PubMed ID: 36909163
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum:
Wang N; Muhetaer G; Zhang X; Yang B; Wang C; Zhang Y; Wang X; Zhang J; Wang S; Zheng Y; Zhang F; Wang Z
Front Pharmacol; 2021; 12():810621. PubMed ID: 35069221
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: SNORA72 activates the Notch1/c-Myc pathway to promote stemness transformation of ovarian cancer cells.
Zhang L; Ma R; Gao M; Zhao Y; Lv X; Zhu W; Han L; Su P; Fan Y; Yan Y; Zhao L; Ma H; Wei M; He M
Front Cell Dev Biol; 2022; 10():819798. PubMed ID: 36092736
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis.
Liao M; Wang C; Yang B; Huang D; Zheng Y; Wang S; Wang X; Zhang J; Tang C; Xu Z; He Y; Huang R; Zhang F; Wang Z; Wang N
Front Pharmacol; 2022; 13():809565. PubMed ID: 35250560
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway.
Kang L; Mao J; Tao Y; Song B; Ma W; Lu Y; Zhao L; Li J; Yang B; Li L
Cancer Sci; 2015 Jun; 106(6):700-708. PubMed ID: 25783790
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis.
Zheng F; Wang Y; Zhang Q; Chen Q; Liang CL; Liu H; Qiu F; Chen Y; Huang H; Lu W; Dai Z
Front Pharmacol; 2023; 14():1201715. PubMed ID: 37205909
[TBL] [Abstract][Full Text] [Related]
9. Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of β-catenin/Notch1/Akt signaling.
Chen JH; T H Wu A; T W Tzeng D; Huang CC; Tzeng YM; Chao TY
Phytomedicine; 2019 Jan; 52():70-78. PubMed ID: 30599914
[TBL] [Abstract][Full Text] [Related]
10. NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties.
Wang LL; Wan XY; Liu CQ; Zheng FM
Mol Med; 2022 May; 28(1):49. PubMed ID: 35508987
[TBL] [Abstract][Full Text] [Related]
11. Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.
Yeo SK; Wen J; Chen S; Guan JL
Cancer Res; 2016 Jun; 76(11):3397-410. PubMed ID: 27197172
[TBL] [Abstract][Full Text] [Related]
12. HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells.
Gallardo-Pérez JC; Adán-Ladrón de Guevara A; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1679-1690. PubMed ID: 28648642
[TBL] [Abstract][Full Text] [Related]
13. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway.
Yang L; Yang M; Cui C; Long X; Li Y; Dai W; Lang T; Zhou Q
Cell Signal; 2023 Jul; 107():110688. PubMed ID: 37105506
[TBL] [Abstract][Full Text] [Related]
14. MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.
Li M; Pan M; You C; Zhao F; Wu D; Guo M; Xu H; Shi F; Zheng D; Dou J
Breast Cancer Res; 2020 Mar; 22(1):26. PubMed ID: 32143670
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells.
Jang GB; Hong IS; Kim RJ; Lee SY; Park SJ; Lee ES; Park JH; Yun CH; Chung JU; Lee KJ; Lee HY; Nam JS
Cancer Res; 2015 Apr; 75(8):1691-702. PubMed ID: 25660951
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction.
Wang F; Mayca Pozo F; Tian D; Geng X; Yao X; Zhang Y; Tang J
Front Pharmacol; 2020; 11():1088. PubMed ID: 32765281
[TBL] [Abstract][Full Text] [Related]
18. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
Kim SH; Singh SV
Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy.
Bhagwat GS; Athawale RB; Gude RP; Md S; Alhakamy NA; Fahmy UA; Kesharwani P
Front Pharmacol; 2022; 13():1123542. PubMed ID: 36712681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
